NCT03519412 2026-03-03ARETHUSAIFOM ETS - The AIRC Institute of Molecular OncologyPhase 2 Completed107 enrolled 14 charts
NCT06625515 2026-02-24First-in-Human Study of ATX-559, an Oral Inhibitor of DHX9, in Patients With Advanced or Metastatic Solid Tumors, and Molecularly Defined CancersAccent TherapeuticsPhase 1 Terminated17 enrolled